Le Lézard
Classified in: Health
Subjects: PET, ANW


LOS ANGELES, March 2, 2023 /PRNewswire/ -- Following his appearance at the WVC annual conference, 4-Time Super Bowl Champion and 5-Time NFL Pro-Bowler Rob "Gronk" Gronkowski, has committed $1 million to pet health start-up, Anivive, for future vaccines, following approval, to help fight Valley Fever and also raised valuable funds for leading pet charities.

Gronkowski attended the veterinary conference in Las Vegas to raise awareness of the work of Anivive, who were named 2022 Best Animal Health Company in North America by S&P Global, and announced the vaccine pledge.

He also took part in a charity bull ride to raise funds for Petco Love, Morris Animal Foundation, Dogtopia Foundation, Banfield Foundation and VCA Charities, which generated $10,000 for the animal charities.

As the proud pet parent to his French Bulldog Ralphie, Gronk is committed to pets and their owners to have access to affordable and innovative care.

Anivive is currently developing an anti-fungal vaccine, which they hope will be available within the next 12 months and may become the first anti-fungal vaccine ever approved for any species. The application of this vaccine could help more than 30 million dogs who are at risk for Valley Fever.

Gronk's donation will allow Anivive's Valley Fever vaccine to be distributed to low-income families and animals within shelters across Arizona.

Rob Gronkowski commented: "I had a blast meeting all the veterinarians and vet nurses at WVC. It cemented my decision to want to be a part of saving pets lives with a company that is making treatments and vaccines that have never been done before.

"Rob's commitment helps us expand our efforts to protect more pets and help them live happy, healthy and longer lives," said Dylan Balsz, Anivive founder & CEO.

Valley Fever is most commonly found in Arizona and Anivive is actively looking for partners to facilitate the donations within the State.

For more information visit: https://www.anivive.com/insider/gronk and follow us on Instagram @anivivelifesciences

Press Contacts:

Thomas Wright: thomas@ballantinespr.com, + 001 424 313 4869

Photo: https://mma.prnewswire.com/media/2014897/ANIVIVE.jpg

SOURCE Anivive

These press releases may also interest you

at 12:47
Medical Weight Loss Clinic(MWLC), a leading provider of physician-supervised weight loss programs in Michigan and Ohio, announced that they are enhancing its prescription medication offerings as part of their comprehensive weight loss programs. MWLC...

at 12:46
A panel of nine distinguished physicians will discuss how they successfully integrated the principles and tools of Yoga Science into their professional medical practices and personal home life at the American Meditation Institute's 12th annual "Heart...

at 12:39
SQI Diagnostics Inc. ("SQI" or the "Company") , a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today announced that the Company's board of directors (the "Board") has issued...

at 12:39
Today, the American Association of Nurse Practitioners® (AANP) and more than 235 organizations sent a letter to the leaders of the U.S. House of Representatives Committee on Ways and Means and the Committee on Energy and Commerce illustrating strong...

at 12:38
Solv today announced the appointment of Teresa Asma to Chief Operating Officer. Asma will help expand Solv's national provider network of quality urgent care centers while supporting the team's work connecting consumers to high quality healthcare...

at 12:30
OrganaBio is thrilled to announce the launch of NeoPACtm placenta and umbilical cord tissues, its latest suite of products designed to accelerate the progress of regenerative medicine and cell therapy. By offering both Research Use Only (RUO) and...

News published on and distributed by: